Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin for Sepsis Induced AKI
NCT05900284Phase 2Completed
- Start
- Nov 2023
- Primary completion
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of liquid metformin (Aspargo Labs) in sepsis, acute kidney injury (AKI). Started Nov 2023; status: completed.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
sepsisacute kidney injury (AKI)
Beyond the preview
Go deeper on NCT05900284.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05900284.